Backed from inside the industry

A lead­ing AI-powered drug dis­cov­ery and devel­op­ment com­pany with a fully integ­rated, end-to-end plat­form.

Hualan integ­rates arti­fi­cial intel­li­gence, phar­ma­ceut­ical expert­ise and industry part­ner­ships across the drug dis­cov­ery and devel­op­ment value chain. Its wholly owned plat­form, Lingqing Digital Intel­li­gence, brings together target dis­cov­ery, small-molecule design, R&D risk pre­dic­tion and phar­ma­ceut­ical data intel­li­gence. This plat­form builds on Hualan's expert­ise in high-end film-coated phar­ma­ceut­ical stop­pers and break­throughs in domestic altern­at­ives to impor­ted pack­aging com­pon­ents, an indus­trial found­a­tion that con­nects its AI cap­ab­il­it­ies with lead­ing drug man­u­fac­tur­ers and real-world devel­op­ment needs.

By con­nect­ing sci­entific intel­li­gence with indus­trial exe­cu­tion, Hualan is shap­ing a more integ­rated, intel­li­gent future for phar­ma­ceut­ical innov­a­tion.

An innov­at­ive research and devel­op­ment plat­form based on quantum phys­ics, powered by arti­fi­cial intel­li­gence, and driven by robot­ics

XtalPi com­bines quantum phys­ics-based first-prin­ciple cal­cu­la­tions, arti­fi­cial intel­li­gence, high-per­form­ance cloud com­put­ing, and scal­able and stand­ard­ized robotic auto­ma­tion to provide global and domestic com­pan­ies in indus­tries such as phar­ma­ceut­ic­als and mater­i­als sci­ence (includ­ing agri­cul­tural tech­no­logy, energy, novel chem­ic­als, and cos­met­ics) with solu­tions and ser­vices for drug and mater­ial sci­ence research and devel­op­ment.